Enrollment for FDA submission concluded
NEW PRODUCT: Launch of antibodies Anti-Factor XII
NGAL studie publiceret
Frost & Sullivan 2014 Best Practices Award
These Terms and Conditions (“Terms") governing the sale of products and related services ("Products”) from BioPorto Diagnostics A/S ("BIOPORTO") and Buyer. Any deviating conditions or reservations by Buyer shall only be binding if confirmed in writing by BIOPORTO. Conditions are also applicable in individual cases where Terms are not attached, but which Buyer has been made aware of the Terms.